DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Neuropathy Peripheral - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Neuropathy Peripheral ()

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include neuropathy peripheral. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of    Next >>

Possible Dexamethasone side effects in

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient:

Reactions: Neuropathy Peripheral, Pneumonia, Post Herpetic Neuralgia, Chronic Obstructive Pulmonary Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-10-01

Velcade
    Dosage: 3.4 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2011-10-06
    End date: 2012-02-02

Other drugs received by patient: Simvastin-Mepha; Enalapril Maleate; Aspirin; Doxazosin Mesylate; Amlodipine; Dyazide



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: female, weighing 87.8 kg (193.2 pounds)

Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma

Cytarabine
    Dosage: 1.87 g, cyclic
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-03-19

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: 2.77 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-12-31

Velcade
    Dosage: 0.7 mg/m2, cyclic

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-02-26

Rituximab
    Dosage: 1 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Methotrexate
    Indication: Mantle Cell Lymphoma

Mesna
    Dosage: 600 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Dexamethasone side effects in 78 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-07

Patient: 78 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Neuropathy Peripheral, Anaemia, Hypotension, Multiple Myeloma, Constipation, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2009-01-29

Revlimid
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-01-29

Dexamethasone
    Start date: 2009-09-10
    End date: 2009-10-01

Revlimid
    Administration route: Oral
    Start date: 2009-09-10
    End date: 2009-10-01

Other drugs received by patient: Heparin; Bisphosphonates



Possible Dexamethasone side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-06

Patient: female

Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, qmo over 4 hrs
    Indication: Multiple Myeloma
    Start date: 2001-10-01
    End date: 2002-01-01

Aredia
    Start date: 2008-07-07

Actos
    Dosage: 30 mg, qhs
    Indication: Diabetes Mellitus

Dexamethasone

Zometa
    Dosage: 4 mg, q2mo infusion over 25 mins every other month
    Indication: Multiple Myeloma
    End date: 2005-07-21

Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-08-03

Patient:

Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram

Bortezomib
    Dosage: 1.3 milligram/sq. meter

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram

Bortezomib
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Bortezomib
    Dosage: 1 milligram/sq. meter

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Dexamethasone
    Dosage: 40 milligram

Bortezomib
    Dosage: .7 milligram/sq. meter

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide



Possible Dexamethasone side effects in 64 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient: 64 year old female

Reactions: Neuropathy Peripheral, Insomnia

Drug(s) suspected as cause:
Dexamethasone

Velcade



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-08-01

Patient: female, weighing 87.8 kg (193.2 pounds)

Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Sinusitis, Leukocytosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Velcade
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-26

Mesna
    Dosage: 1122mg in normal saline 2000 ml over 24 hours daily for 3 days on days 2-4
    Indication: Mantle Cell Lymphoma

Cytarabine
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 94 mg over 15 minutes for 1 dose on day 5
    Indication: Mantle Cell Lymphoma

Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Velcade

Velcade
    Dosage: push over 3-5 seconds
    Start date: 2012-03-19
    End date: 2012-03-19

Methotrexate
    Indication: Mantle Cell Lymphoma

Rituximab
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: on days 2-5 and days 12-15
    Administration route: Oral
    Indication: Mantle Cell Lymphoma

Velcade
    Start date: 2011-12-31

Vincristine
    Dosage: on day 5 and day 12
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sodium Chloride; Tramadol HCL; Leucovorin Calcium; Leucovorin Calcium; Unknown Medication; Morphine Sulfate; Sodium Chloride; Neupogen; Zofran; Sennosides-Docusate Sodium; Ondansetron HCL; Potassium Chloride; Sodium Chloride; Heparin; Zofran; Sodium Bicarbonate; Meperidine HCL; Diphenhydramine HCL; Nystatin; Lovenox; Sodium Chloride; Senokot; Allopurinol; Ciprofloxacin HCL; Fluconazole; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Valtrex; Ondansetron HCL



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31

Patient:

Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Renal Disorder, Drug Effect Decreased, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Velcade
    Dosage: on days 1, 4, 8 and 11
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: on day 1 (and day 8 of cycle 1)
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29.
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4

Doxorubicin Hydrochloride
    Dosage: as a continuous infusion from day 1 to 4
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: day 1 to 4
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from Spain on 2012-07-30

Patient:

Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
    Indication: Multiple Myeloma

Thalomid
    Dosage: 200mg daily (escalating doses in the first cycle)
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23

Patient: male

Reactions: Cholelithiasis, Neuropathy Peripheral

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    End date: 2012-01-17

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-07-13

Elotuzumab
    Dosage: 20 milligram/kilogram
    Indication: Multiple Myeloma
    Start date: 2011-07-13
    End date: 2012-01-11

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2011-07-12
    End date: 2012-01-18

Other drugs received by patient: Mecobalamin; Pregabalin



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-19

Patient:

Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Drug Effect Decreased, Renal Disorder, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Rituximab
    Dosage: on day 1 (and day 8 of cycle 1)
    Indication: Mantle Cell Lymphoma

Doxorubicin HCL
    Dosage: as a continuous infusion from day 1 to 4
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: on days 1, 4, 8 and 11
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: day 1 to 4
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: from day 20 to 29.
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Dexamethasone side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient: 50 year old male

Reactions: Neuropathy Peripheral

Drug(s) suspected as cause:
Velcade
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Revlimid
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-07-16

Patient:

Reactions: Pulmonary Toxicity, Gastrointestinal Toxicity, Nephropathy Toxic, Anaemia, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Sepsis, Cardiotoxicity, Neutropenia, Thrombocytopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: continuous infusion for 4 days. form: infusion.
    Indication: Mantle Cell Lymphoma

Chlorambucil
    Dosage: d20 to d29. one cycle every 35 days.
    Indication: Mantle Cell Lymphoma

Bortezomib
    Dosage: drug: ps 341 on d1, 4, 8 and 11 of cycle 1.
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: from day 1 to 4.
    Indication: Mantle Cell Lymphoma

Mabthera
    Dosage: day 1 (and day 8 for cycle 1).
    Indication: Mantle Cell Lymphoma



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from Greece on 2012-07-11

Patient: female, weighing 96.0 kg (211.2 pounds)

Reactions: Myalgia, Neuropathy Peripheral, Muscular Weakness, Neuralgia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Velcade
    Dosage: days 1,4,8,11 of cycle
    Start date: 2009-12-14

Velcade
    Dosage: days 1,4,8,11 of cycle
    Start date: 2010-01-28

Dexamethasone
    Dosage: days 1-4, 9-12, 17-20 of cycle
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-10-30

Doxorubicin HCL
    Dosage: on day 1
    Start date: 2009-12-14

Dexamethasone
    Dosage: 1 in 1 month
    Administration route: Oral
    Start date: 2010-01-29

Doxorubicin HCL
    Dosage: on day 1
    Start date: 2010-01-28

Velcade
    Dosage: days 1,4,8,11 of cycle
    Indication: Multiple Myeloma
    Start date: 2009-10-30

Dexamethasone
    Dosage: days 1-4
    Administration route: Oral
    Start date: 2009-12-14

Doxorubicin HCL
    Dosage: on day 1
    Indication: Multiple Myeloma
    Start date: 2009-10-30



Possible Dexamethasone side effects in 71 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-10

Patient: 71 year old male, weighing 82.0 kg (180.4 pounds)

Reactions: Prostate Cancer, Anaemia, Cushing's Syndrome, Dysgeusia, Osteoarthritis, Syncope, Neuropathy Peripheral, Fatigue, Arthralgia, Carbuncle, Dehydration, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 1.5 milligram
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2008-10-01

Dexamethasone
    Dosage: 1.5 milligram

Celecoxib
    Dosage: 400 milligram
    Indication: Prostate Cancer
    Start date: 2008-10-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-04-15
    End date: 2011-06-09

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-06-10
    End date: 2011-08-03

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2009-12-18

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2009-09-14
    End date: 2009-12-17

Dexamethasone
    Dosage: .75 milligram
    Administration route: Oral
    Start date: 2009-04-01

Other drugs received by patient: Acetylsalicylacid; Metformin HCL; Metoprolol



Possible Dexamethasone side effects in female

Reported by a lawyer from United States on 2012-07-02

Patient: female

Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Toxic Nodular Goitre, Left Ventricular Hypertrophy, Nasal Congestion, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Folliculitis, Fall, Gastric Ulcer, Hyperparathyroidism, Aortic Arteriosclerosis, Thyroid Mass, Perineurial Cyst, Depression, Renal Failure Acute, Decreased Appetite, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Pulmonary Valve Incompetence, Syncope, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Gait Disturbance, Dysaesthesia, Respiratory Tract Infection, Leukopenia, Weight Decreased, Vitamin D Deficiency, Goitre, Lower Limb Fracture, Herpes Zoster, Uterine Leiomyoma, Hypomagnesaemia, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Stomatitis, Chest Discomfort, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Sinusitis, RIB Fracture, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, qmo over 4 hrs
    Indication: Multiple Myeloma
    Start date: 2001-10-01
    End date: 2002-01-01

Dexamethasone

Aredia
    Start date: 2008-07-07

Actos
    Dosage: 30 mg, qhs
    Indication: Diabetes Mellitus

Zometa
    Dosage: 4 mg, q2mo infusion over 25 mins every other month
    Indication: Multiple Myeloma
    End date: 2005-07-21

Other drugs received by patient: Xanax; Procrit / 00909301 /; Pentamidine Isethionate; Crestor; Enalapril Maleate; Magnesium Oxide; Vincristine + Adriamycin + Dexamethasone; Aspirin; Augmentin '125'; Benadryl; Decadron; Thalidomide; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Avalide; Potassium Chloride; Influenza Vaccine; Melphalan Hydrochloride; Metformin HCL; Doxil; Alkeran; Fortamet; Chemotherapeutics NOS; Hepatitis B Vaccine; Cyclophosphamide; Cytoxan; Pneumovax 23; Polio-Vaccine; Revlimid; Velcade; Prednisone TAB; Norvasc



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-06-29

Patient:

Reactions: Anaemia, Febrile Neutropenia, Rash, Multiple Myeloma, Pyrexia, Stem Cell Transplant, Myeloma Recurrence, Neuropathy Peripheral, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 300 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 20 milligram
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in 78 year old male

Reported by a physician from United States on 2012-06-28

Patient: 78 year old male

Reactions: Neuropathy Peripheral, Injection Site Reaction, Toxic Epidermal Necrolysis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-08-01

Velcade
    Dosage: unk
    Start date: 2011-08-16
    End date: 2011-08-16

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2009-03-01
    End date: 2009-05-01

Lenalidomide
    Dosage: unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-01

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2009-03-01
    End date: 2009-05-01



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-28

Patient:

Reactions: Neuropathy Peripheral, Adverse Drug Reaction, Neutropenia, Multiple Myeloma, Thrombocytopenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: induction therapy

Prednisone TAB
    Dosage: post induction therapy; of a 28-day cycle
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: post induction therapy; days 1, 8, 15, 22
    Administration route: Oral
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: induction therapy
    Indication: Multiple Myeloma

Bortezomib
    Dosage: post-induction therapy, days 1, 8, 15
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: maintainance therapy
    Indication: Multiple Myeloma

Bortezomib
    Dosage: induction therapy



Possible Dexamethasone side effects in 70 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27

Patient: 70 year old male

Reactions: Furuncle, Anaemia, Cushing's Syndrome, Dysgeusia, Osteoarthritis, Neuropathy Peripheral, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Celecoxib
    Dosage: 400 milligram
    Indication: Prostate Cancer Metastatic

Dexamethasone
    Indication: Prostate Cancer Metastatic
    Start date: 2009-04-01

Dexamethasone
    Start date: 2009-07-01

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2010-06-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Dexamethasone
    Start date: 2010-03-01

Dexamethasone



Possible Dexamethasone side effects in 70 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26

Patient: 70 year old male

Reactions: Anaemia, Furuncle, Cushing's Syndrome, Osteoarthritis, Dysgeusia, Neuropathy Peripheral, Thrombocytopenia, Leukopenia

Drug(s) suspected as cause:
Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Prostate Cancer Metastatic
    Start date: 2010-06-01

Dexamethasone

Dexamethasone
    Start date: 2010-03-01

Celecoxib
    Dosage: 400 milligram
    Indication: Prostate Cancer Metastatic

Dexamethasone
    Start date: 2009-07-01

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Dexamethasone
    Indication: Prostate Cancer Metastatic
    Start date: 2009-04-01



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-06-15

Patient:

Reactions: Anaemia, Multiple Myeloma, Toxicity To Various Agents, Hypokalaemia, Death, Hypophosphataemia, Neuropathy Peripheral, Fatigue, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carfilzomib
    Dosage: days 8, 9, 15, 16 every 28 days
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Indication: Multiple Myeloma

Steroids NOS
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 1.5 to 3 mg/m^2/day
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Cisplatin
    Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: day 1, 2

Thalidomide
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
    Indication: Multiple Myeloma

Bortezomib
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08

Patient:

Reactions: Anaemia, Toxicity To Various Agents, Multiple Myeloma, Hypokalaemia, Death, Hypophosphataemia, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Carfilzomib
    Dosage: days 8, 9, 15, 16 every 28 days
    Indication: Multiple Myeloma

Melphalan Hydrochloride
    Indication: Multiple Myeloma

Cisplatin
    Dosage: (3-5 mg/m^2/day) 16 days continuous infusion
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: in the absence of at least partial response (pr), dex increased to 20 mg
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Bortezomib
    Indication: Multiple Myeloma

Lenalidomide
    Indication: Multiple Myeloma

Steroids NOS
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: 1.5 to 3 mg/m^2/day
    Indication: Multiple Myeloma

Carfilzomib
    Dosage: day 1, 2



Possible Dexamethasone side effects in 78 year old male

Reported by a physician from United States on 2012-06-07

Patient: 78 year old male

Reactions: Neuropathy Peripheral, Injection Site Reaction, Toxic Epidermal Necrolysis

Drug(s) suspected as cause:
Lenalidomide
    Dosage: unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-01

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2009-03-01
    End date: 2009-05-01

Velcade
    Dosage: unk
    Start date: 2011-08-01

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2009-03-01
    End date: 2009-05-01

Dexamethasone
    Dosage: unk
    Administration route: Oral
    Start date: 2011-08-01



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-06-01

Patient: female, weighing 34.6 kg (76.0 pounds)

Reactions: Weight Decreased, Neuropathy Peripheral

Drug(s) suspected as cause:
Revlimid
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-08-09

Velcade
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-08-09

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-08-09



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-05-24

Patient:

Reactions: Off Label Use, Neuropathy Peripheral, Cerebrovascular Accident

Drug(s) suspected as cause:
Cytarabine
    Dosage: hd; in h patients; days 43, 44; previous protocol; re-induction phase
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 on days 1, 8, previous protocol, consolidation phase

Mercaptopurine
    Dosage: days 1-14, previous protocol, consolidation phase

Prednisone
    Dosage: days 1-29, previous protocol, re-induction
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: every 4 weeks, previous protocol, continuation

Elspar
    Dosage: 10,000 u/m2 or 25, 000u/m2 on days 2,4,6,8,10,12 previous protocol, remission induction
    Indication: Acute Lymphocytic Leukaemia

Cytoxan
    Dosage: stable/high, every 8 weeks, previous protocol, continuation
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL

Vincristine
    Dosage: on days 1, 8, 15, 22, previous protocol, remission induction

Methotrexate
    Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 every 8 weeks during 1 year, previous protocol, continuation phase

Prednisone
    Dosage: days 1-29, previous protocol, remission induction

Etoposide
    Dosage: on days 22, 29, 32, previous protocol, re-induction

Methotrexate
    Dosage: age dependent dose on days 1,8,previous protocol, consolidation

Methotrexate
    Dosage: weekly; previous protocol; continuation phase

Cytarabine
    Dosage: every 8 weeks, previous protocol, continuation

Cytarabine
    Dosage: days 22,29, 32, previous protocol, re-induction

Dexamethasone
    Dosage: every 4 weeks, previous protocol, continuation
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: on days 1, 8 and extra on day 15, previous protocol, re-induction
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: on days 1, 8, 15, 22, previous protocol, re-induction induction
    Indication: Acute Lymphocytic Leukaemia

Elspar
    Dosage: 10,000 u/m2 or 25,000u/m2 on days 2,4,6,8,10,12 previous protocol, reinduction

Elspar
    Dosage: 10,000 u/m2 or 25,000u/m2 thrice weekly(reinduction i, ii), weekly (reinduction i) previous protocol

Elspar
    Dosage: 25,000u/m2 weeklyduring first 19 weeks; previous protocol; continuation

Cytarabine
    Dosage: on days 22, 29, 32, previous protocol, remission induction

Etoposide
    Dosage: on days 22, 29, 32, previous protocol, remission induction
    Indication: Acute Lymphocytic Leukaemia

Etoposide
    Dosage: every 4 weeks, previous protocol, continuation

Methotrexate
    Dosage: age dependent dose on days 1, 22 (extra 8, 15), previous protocol, remission induction
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: previous protocol, continuation phase

Methotrexate
    Dosage: age dependent dose on days 1, 22, previous protocol, re-induction phase

Mercaptopurine
    Dosage: daily, previous protocol, continuation phase
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Cotrim; Leucovorin Calcium



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-05-16

Patient:

Reactions: Off Label Use, Neuropathy Peripheral, Hyperglycaemia, Neutropenic Sepsis, Pancreatitis, Cerebrovascular Accident, Ketoacidosis, Convulsion

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: on days 1, 8, current protocol, remission induction
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: on days 1, 8 and extra on day 15, previous protocol, re-induction

Doxorubicin HCL
    Dosage: in low, standard and high risk patients; day 1 (reinduction i, ii) and days 1, 8 (in reinduction i)

Cytarabine
    Dosage: hd; in s/h patients; days 15-16 in reinduction ii; current protocol
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: age dependent dose on day 8,15,29, current protocol, consolidation

Vincristine
    Dosage: on days 1, 8, 15, 22, current protocol, remission induction

Cytarabine
    Dosage: every 4 weeks, current protocol, continuation

Mercaptopurine
    Dosage: daily, previous protocol, continuation phase
    Indication: Acute Lymphocytic Leukaemia

Mercaptopurine
    Dosage: days 15-70, current protocol, consolidation phase

Mercaptopurine
    Dosage: 50-70 mg/m2, daily, current protocol, continuation phase

Methotrexate
    Dosage: age dependent dose on days 1, 22, previous protocol, re-induction phase

Methotrexate
    Dosage: weekly; previous protocol; continuation phase

Methotrexate
    Dosage: weekly; current protocol; continuation phase

Doxorubicin HCL
    Dosage: in s/h patients; every 3 weeks during first 16 weeks, continuation phase,current protocol

Vincristine
    Dosage: every 4 weeks, current protocol, continuation phase

Elspar
    Dosage: 10,000 u/m2 or 25,000u/m2 on days 2,4,6,8,10,12 previous protocol, reinduction

Elspar
    Dosage: 25,000u/m2 weeklyduring first 19 weeks; previous protocol; continuation

Cytarabine
    Dosage: on days 22, 29, 32, previous protocol, remission induction

Cytarabine
    Dosage: days 22,29, 32, previous protocol, re-induction

Mercaptopurine
    Dosage: days 1-14, previous protocol, consolidation phase

Methotrexate
    Dosage: age dependent dose on days 1; current protocol, re-induction phase
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 every 8 weeks during 1 year, previous protocol, continuation phase

Prednisone
    Dosage: days 1-28, current protocol, remission induction

Prednisone
    Dosage: days 1-29, previous protocol, remission induction

Cyclophosphamide
    Dosage: stable/high, every 4 weeks, current protocol, continuation
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: l:2.5 g/m2, s/h: 5 g/m2 on days 1, 15,29,43,57, current protocol, consolidation phase

Elspar
    Dosage: 10,000 u/m2 or 25, 000u/m2 on days 2,4,6,8,10,12 previous protocol, remission induction

Etoposide
    Dosage: on days 22, 29, 32, previous protocol, remission induction

Cyclophosphamide
    Dosage: stable/high, every 8 weeks, previous protocol, continuation

Methotrexate
    Dosage: age dependent dose on days 1, 22 (extra 8, 15), previous protocol, remission induction

Dexamethasone
    Dosage: low risk 8 mg/m2, 5 days, stable/high risk 12 mg/m2, every 4 weeks, current protocol, continuation

Doxorubicin HCL
    Dosage: on days 1, 8 and extra on day 15, previous protocol, remission induction

Vincristine
    Dosage: on days 1, 8, 15, 22, previous protocol, remission induction
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on days 23-26, 29-32, current protocol, remission-induction

Etoposide
    Dosage: every 4 weeks, previous protocol, continuation

Mercaptopurine
    Dosage: days 22-35, current protocol, remission-induction

Methotrexate
    Dosage: age dependent dose on days 1,8,previous protocol, consolidation

Vincristine
    Dosage: on days 1, 8, 15, 22, previous protocol, re-induction induction

Vincristine
    Dosage: every 4 weeks, previous protocol, continuation

Cytarabine
    Dosage: hd; in h patients; days 43, 44; previous protocol; re-induction phase

Cyclophosphamide
    Dosage: on day 26, current protocol, remission-induction

Methotrexate
    Dosage: age dependent dose every 4 weeks during 1 year current protocol, continuation phase

Dexamethasone
    Dosage: every 4 weeks, previous protocol, continuation
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: l:1.5 g/m2, s: 2g/m2, h: 5 g/m2 on days 1, 8, previous protocol, consolidation phase

Prednisone
    Dosage: days 1-29, previous protocol, re-induction induction
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: on days 1, 8, 15, current protocol, re-induction induction

Elspar
    Dosage: 10,000 u/m2 or 25,000u/m2 thrice weekly(reinduction i, ii), weekly (reinduction i) previous protocol
    Indication: Acute Lymphocytic Leukaemia

Elspar
    Dosage: 10,000 u/m2 on days 2,4,6,8,10,12 (15, 17, 19)current protocol, remission induction

Cytarabine
    Dosage: every 8 weeks, previous protocol, continuation

Etoposide
    Dosage: on days 22, 29, 32, previous protocol, re-induction
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: previous protocol, continuation phase

Methotrexate
    Dosage: age dependent dose on days 1, 15 (extra on 8, 22), current protocol, remission-induction

Dexamethasone
    Dosage: days 1-8, 15-22, current protocol, remission-induction

Other drugs received by patient: Cotrim; Leucovorin Calcium



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014